213 related articles for article (PubMed ID: 32338082)
1. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases.
Cheng CW; Wu CZ; Tang KT; Fang WF; Lin JD
Autoimmunity; 2020 Aug; 53(5):261-269. PubMed ID: 32338082
[TBL] [Abstract][Full Text] [Related]
2. Synchronized expressions of serum osteopontin and B cell-activating factor in autoimmune thyroid disease.
Cheng CW; Tang KT; Fang WF; Lin JD
Eur J Clin Invest; 2019 Jul; 49(7):e13122. PubMed ID: 31034586
[TBL] [Abstract][Full Text] [Related]
3. Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease.
Wang X; Huang J; Zhang A; Fang C; Ma Q; Jiang P
BMC Endocr Disord; 2021 Apr; 21(1):88. PubMed ID: 33926416
[TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
5. Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease.
Lin JD; Wang YH; Fang WF; Hsiao CJ; Chagnaadorj A; Lin YF; Tang KT; Cheng CW
Clin Chim Acta; 2016 Nov; 462():96-102. PubMed ID: 27616625
[TBL] [Abstract][Full Text] [Related]
6. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease.
Qin Q; Liu P; Liu L; Wang R; Yan N; Yang J; Wang X; Pandey M; Zhang JA
Braz J Med Biol Res; 2012 Dec; 45(12):1202-8. PubMed ID: 23090124
[TBL] [Abstract][Full Text] [Related]
7. The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases.
Jiskra J; Antosová M; Límanová Z; Telicka Z; Lacinová Z
Clin Exp Immunol; 2009 May; 156(2):211-6. PubMed ID: 19250272
[TBL] [Abstract][Full Text] [Related]
8. Low serum interleukin-38 levels in patients with Graves' disease and Hashimoto's thyroiditis.
Xu J; Huang G; Weng L; Gong L; Mao Y; Li Y; Li M
J Clin Lab Anal; 2022 Jan; 36(1):e24101. PubMed ID: 34799942
[TBL] [Abstract][Full Text] [Related]
9. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.
Song RH; Yu ZY; Qin Q; Wang X; Muhali FS; Shi LF; Jiang WJ; Xiao L; Li DF; Zhang JA
Int J Clin Exp Pathol; 2014; 7(7):4024-31. PubMed ID: 25120780
[TBL] [Abstract][Full Text] [Related]
10. Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis.
Kim D
Hormones (Athens); 2016 Jul; 15(3):385-393. PubMed ID: 27394703
[TBL] [Abstract][Full Text] [Related]
11. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
12. Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
Cheng CW; Fang WF; Lin JD
PLoS One; 2023; 18(11):e0289345. PubMed ID: 38019813
[TBL] [Abstract][Full Text] [Related]
13. Associations of gene polymorphisms in interferon-alpha signature-related genes with autoimmune thyroid diseases.
Lin JD; Yang SF; Wang YH; Fang WF; Tang KT; Cheng CW
Clin Endocrinol (Oxf); 2019 Dec; 91(6):860-868. PubMed ID: 31494956
[TBL] [Abstract][Full Text] [Related]
14. Serum interferon levels associated with the disease activity in women with overt Graves' disease.
Cheng CW; Fang WF; Tang KT; Lin JD
Cytokine; 2021 Feb; 138():155353. PubMed ID: 33121876
[TBL] [Abstract][Full Text] [Related]
15. B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid Diseases.
Campi I; Tosi D; Rossi S; Vannucchi G; Covelli D; Colombo F; Trombetta E; Porretti L; Vicentini L; Cantoni G; Currò N; Beck-Peccoz P; Bulfamante G; Salvi M
Thyroid; 2015 Sep; 25(9):1043-9. PubMed ID: 26214745
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response.
Hiratsuka I; Itoh M; Yamada H; Yamamoto K; Tomatsu E; Makino M; Hashimoto S; Suzuki A
Endocr J; 2015; 62(12):1059-66. PubMed ID: 26400025
[TBL] [Abstract][Full Text] [Related]
17. Differential serum interferon-β levels in autoimmune thyroid diseases.
Cheng CW; Tang KT; Fang WF; Lee TI; Lin JD
Arch Med Sci; 2022; 18(5):1231-1240. PubMed ID: 36160354
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy.
Gu X; Zheng L; Chen X; Ruan L; Zhang H; Ge S; Zhu H; Lin X; Shen F
Horm Metab Res; 2012 Jun; 44(6):482-7. PubMed ID: 22473756
[TBL] [Abstract][Full Text] [Related]
19. Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1β in Hashimoto's thyroiditis but not in Graves' disease.
Zake T; Skuja S; Kalere I; Konrade I; Groma V
Endocr J; 2019 May; 66(5):423-430. PubMed ID: 30814438
[TBL] [Abstract][Full Text] [Related]
20. Myeloid related proteins are up-regulated in autoimmune thyroid diseases and activate toll-like receptor 4 and pro-inflammatory cytokines in vitro.
Peng S; Sun X; Wang X; Wang H; Shan Z; Teng W; Li C
Int Immunopharmacol; 2018 Jun; 59():217-226. PubMed ID: 29656212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
